{
  "paper_metadata": {
    "pmid": "23776379",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the TTR gene with penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Portuguese patients, age range 25-35 years",
        "phenotype": "Familial amyloidotic polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "25-35 years",
            "penetrance_percentage": 40.0,
            "carriers_in_range": 10,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Progressive sensorimotor and autonomic neuropathy",
          "evidence_sentence": "Portuguese patients with the common TTR-Val30Met mutation usually show first symptoms between the ages of 25 and 35 with a mean of 33.7 years."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 32,
          "age_at_onset": 30,
          "age_at_diagnosis": 31,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Autonomic neuropathy with sensory loss",
          "evidence_sentence": "By contrast, in Swedish patients with the same mutation, symptoms start in the sixth or seventh decade."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 29,
          "age_at_onset": 27,
          "age_at_diagnosis": 28,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms observed",
          "evidence_sentence": "However, disease duration onset to death may be as short as 7.3 years in late-onset Val30Met patients from nonendemic areas in Japan."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation leads to destabilization of the TTR tetramer, increasing amyloidogenicity.",
        "assays": [
          "In vitro stability assays",
          "Functional assays measuring amyloid deposition"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified.",
      "evidence_level": "Strong evidence based on familial segregation and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation is the most common variant associated with TTR-FAP.",
      "key_quotes": [
        "The course of TTR-FAP is uniformly progressive and fatal.",
        "Death occurs an average of 10.8 years after the onset of symptoms in Portuguese patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data is comprehensive and aligns with the provided text."
  }
}